SON Clinical Trials

1,069 recruitingLast updated: May 13, 2026

There are 1,069 actively recruiting son clinical trials across 60 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, Beijing, Beijing Municipality, China, New York, New York, United States. Updated daily from ClinicalTrials.gov.


SON Trials at a Glance

1,069 actively recruiting trials for son are listed on ClinicalTrialsFinder across 6 cities in 60 countries. The largest study group is Not Applicable with 501 trials, with the heaviest enrollment activity in Boston, Beijing, and New York. Lead sponsors running son studies include University of Minnesota, VA Office of Research and Development, and Radboud University Medical Center.

Treatments under study

About SON Clinical Trials

Looking for clinical trials for SON? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new SON trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about SON clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,069 trials

Recruiting
Phase 3

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals300 enrolled2 locationsNCT07498426
Recruiting
Phase 1

Relative Bioavailability Study of HNC364 Injectable Suspension

Parkinson's Disease (PD)
Guangzhou Henovcom Bioscience Co. Ltd.30 enrolled1 locationNCT06798519
Recruiting
Phase 2

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Parkinson Disease
Hillhurst Biopharmaceuticals, Inc.36 enrolled1 locationNCT07005180
Recruiting
Not Applicable

A Precision Medicine Approach to Target Engagement for Emotion Regulation

DepressionAnxietyEating Disorders+4 more
Matthew Southward, PhD390 enrolled1 locationNCT05651295
Recruiting
Not Applicable

The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease

Parkinson's Disease
The First Affiliated Hospital of Anhui Medical University90 enrolled1 locationNCT07572903
Recruiting
Phase 1Phase 2

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

Parkinson Disease
iRegene Therapeutics Co., Ltd.5 enrolled1 locationNCT07102342
Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Parkinson's Disease
Boston Scientific Corporation1,500 enrolled84 locationsNCT02071134
Recruiting
Not Applicable

Aim 3 Particle Swarm Optimization PIGD

Parkinson's Disease and Parkinsonism
University of Minnesota30 enrolled1 locationNCT05934747
Recruiting
Not Applicable

Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF)

Parkinson Disease
University Hospital, Toulouse34 enrolled1 locationNCT06008704
Recruiting
Not Applicable

Patient-Specific 3D Action Observation Training in Parkinson's Disease

Virtual RealityParkinson DiseaseImmersive Virtual Reality+2 more
Abant Izzet Baysal University24 enrolled1 locationNCT07250672
Recruiting
Early Phase 1

Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder

Parkinson Disease
University of Minnesota60 enrolled1 locationNCT05893186
Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Movement DisordersParkinson DiseaseDystonia+1 more
Boston Scientific Corporation200 enrolled4 locationsNCT06553625
Recruiting

Investigations of Dementia in Parkinson Disease

Parkinsons
Washington University School of Medicine320 enrolled1 locationNCT02763683
Recruiting

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Parkinson DiseaseDystoniaEssential Tremor
Boston Scientific Corporation5,000 enrolled19 locationsNCT03664609
Recruiting
Not Applicable

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

Magnetic Resonance ImagingEcological Momentary AssessmentAttentional Bias+4 more
University of Arkansas255 enrolled1 locationNCT05336188
Recruiting
Phase 2

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease

DepressionParkinson DiseasePARKINSON DISEASE (Disorder)
University of British Columbia60 enrolled1 locationNCT05568498
Recruiting
Not Applicable

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

Parkinson Disease
Sanmai Technologies PBC dba Sanmai60 enrolled2 locationsNCT07207122
Recruiting
Not Applicable

Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting

Parkinson DiseaseDeep Brain Stimulation
University of Florida60 enrolled1 locationNCT07410598
Recruiting

AID-FOG: Artificial Intelligence-Driven Freezing of Gait Detection in the Home

Parkinson Disease, IdiopathicFreezing of GaitArtifical Intelligence+2 more
KU Leuven126 enrolled3 locationsNCT07580612
Recruiting

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

Schizophrenia DisordersPersonality DisordersDepression Disorders+1 more
University of Edinburgh100 enrolled1 locationNCT07398365